Dr. Altay Aliyev
Internal Medicine and Medical Oncology Specialist
Chief of Medical Oncology Departament
Education and Work Experience:
2004 -2010 Istanbul University, Istanbul Faculty of Medicine
2011-2015 Istanbul University, Istanbul Faculty of Medicine, Internal Medicine Residency,
2013-2014 Cleveland Clinic Endocrinology Research Fellow
2016-2019 Bezmi Alem University, Faculty of Medicine, Medical Oncology Fellowship
Internal Medicine Speciality Dissertation: Prognostic Value of Absolute Monocyte Count in Mantle Cell Lymphoma Patients.
Medical Oncology Fellowship Dissertation: The Effect of Adjuvant Chemotherapy on Lipid Profile and Anthropometric Parameters in Breast and Colon Cancer Patients.
Specialty in Diseases & Conditions:
- Cancer Prevention, screening and diagnosis.
- Palliative and Supportive care.
- Cytotoxic chemotherapy.
- Hormone therapy.
- Targeted treatment.
Publications on Sci- Expended Journals:
- Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggresiveness in Patients With Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr Pract.2015 Jul;21(7):777-81. doi: 10.4158/EP14425.OR. Epub 2015 Mar 18.
- The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer.
Aliyev A, Soundararajan S, Bucak E et al. Surgery. 2015 Oct;158(4):1089-93; discussion 1093-4. doi: 10.1016/j.surg.2015.06.023. Epub 2015 Jul 23.
- Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9.
- Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat.2018;41(9):545-549. doi: 10.1159/000490120. Epub 2018 Aug 20.
- Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan;83(1):131-143. doi: 10.1007/s00280-018-3712-7. Epub 2018 Oct 30.
- Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: S0147-0272(19)30060-1. doi: 10.1016/j.currproblcancer.2019.06.009.
- Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal.
- Treatment Modalities for Stage IV Diseases in Colorectal Cancer 6th Meeting 6-11 May 2018 Istanbul. Evaluation bone Metastases risk factors in colorectal Cancer Patients. Kolorektal kanserli hastalarda kemik metastazı risk faktörlerinin değerlendirilmesi. Tarık Demir, Altay Aliyev.
- Treatment Modalities for Stage IV Diseases in Colorectal Cancer 6th Meeting 6-11 May 2018 Istanbul. Rare brain metastasis of colorectal cancers: risk factors, prognosis and clinical features. Altay Aliyev, Tarık Demir,et al.
- 8 th International Gastrointestinal Cancer Conference 7-9 December Istanbul. Rare brain metastasis of colorectal cancers: risk factors, prognosis and clinical features. Tarık Demir, Altay Aliyev.
- Actual Devoloping in Cancer. Lung Cancer. Diyarbakır 2018. Clinical Features of Malignant Patients with Pulmnary Embolism. Altay Aliyev.
- 23rd National Cancer Congress. Antalya 2019. Pathological Complete Response Related Factors in Breast Cancer Patients Receiving Neoadjuvant Chemotheraphy. Ezgi Çoban, Mehmet Beşiroğlu, Altay Aliyev, et al.
- 23rd National Cancer Congress. Antalya 2019. Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma? Tarık Demir, Murat Araz, Altay Aliyev, et al.
- 2nd Eskishehir Oncology Meeting. April 2019. The Effect of Adjuvant Chemotherapy on Lipid Profile and Anthropometric Parameters in Breast and Colon Cancer Patients. Altay Aliyev, Mehmet Besiroglu.
- KLIMIK 2016 30. Yıl Kurultayı. Mart 2016 Antalya. Colistin-Resistant Klebsiella pneumoniae-Induced Pylephlebitis Caused by Continuous Bacteremia: A Case Treated with Interventional Radiological Method.. Vasif Aliyev, Altay Aliyev, et al.
- Health Sciences University Internal Medicine Congress. 26-30 June 2018 Istanbul. Prognostic Value of Absolute Monocyte Count in Mantle Cell Lymphoma Patients. Altay Aliyev, Tarık Demir, Meliha Nalcacı.
- 2 nd International Congress on Oncological Sciences.20-23 September Antalya. The C-Reactive Protein/ Albumin Ratio, A Novel Inflammation- Based Prognostic Score, Predicts Outcomes in Patients With Biliary Tract Cancer. Tarık Demir, Altay Aliyev, et al.
- 35th National Congress of Nephrology, Hypertension, Dialysis and Transplantation. October 2018 Antalya. Long-Term Effect of Chemotherapy on Renal Function in Patients with Cancer. Elgun Haziyev, Meltem Gursu, Altay Aliyev, et al.
International Phase II-III studies that I participated as a researcher:
- Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma. Protokol Code:WO30070
- Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors.
- A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU).
- A Study of FPA144 Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer (FIGHT).
- ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection.
- Study of REGN2810 (Anti-PD-1) in Advanced NSCLC Patients With.
- 22nd National Cancer Congress. 19-23 April 2017 Antalya. Clinical Features and Prognostic Factors of Hepatocellular Cancer Patients with Follow-up at Eskişehir Osmangazi University Servet Bilir Oncology Center. Altay Aliyev, Pınar Dal, et al.
- 22nd National Cancer Congress. 19-23 April 2017 Antalya. Clinical and Pathological Parameters Affecting Surgical Boundary Proximity / Positivity in Operated Breast Cancer Patients. Nuray Bali, Bülent Yıldız,Altay Aliyev, et al.
- ASCO 2019 Annual Meeting. Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer. Ulas Isık, Osman Kostek, Altay Aliyev et al. J Clin Oncol 37, 2019 (suppl; abstr e16075).
Courses and Congresses:
- Hedef Kanser 2017 6-8 Aprel Kipr.
- Post graduated courses/ Basic Education of Clinical Trials/19-20 November 2016 İzmir
- Post graduated courses / İnteraktif Toraks Onkoloji Kursu/16-17 Sentyabr 2017 İstanbul
- Post graduated courses / Interactive Breast Cancer Course/23-24 Dekabr 2017 İstanbul
- Post graduated courses / Gastrointestinal System Malignancy Course/ 10-11 Fevral 2018 Ankara
- Post graduated courses / Hematologic Malignancy Course/ 5-6 May 2018 İstanbul
- ASCO 2018/1-5 İyun 2018 Chicago, USA
- Best of ASCO 2018/23 June İstanbul
- Euroasian Uro-Oncology Congress/ 28.6-1.7.2018 Tiflis
- Turkish Medical Oncology Congress / 21-25 March 2018 Antalya
- Post graduated courses / Gynecological Malignancy Course /8-9 September Izmir
- Post graduated courses / Head and Neck Malignancy Course/24-25 Noyabr 2018 Istanbul
- Post graduated courses / Central Nervous System Malignancy and Sarcom’s Course/ 9-10 Feburary 2019 Izmir
- Post graduated courses / Urological Malignancy Course/ 4-5 May 2019 Ankara
- Course of Supportive Care and Palliation in Cancer Patients/15-16 June Adana
- Best of ASCO 2019/ 22 June Istanbul
Turkish Society of Medical Oncology
ESMO: European Society for Medical Oncology
ASCO: American Society of Clinical Oncology